Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... and royalties on any worldwide commercial sales. The program was begun in 2007 with Wyeth, which was acquired by Pfizer last month. The program leverages Flamel's ability to ...
2009 NOV 24 ... include ACLU, City of Edmonton, Laureate Education, Maple Leaf Foods, MRA, USAID, and Wyeth Consumer Healthcare. These organizations are using Presto for a faster and more ...
2009 NOV 28 ... the Company has licensed the use of its proprietary MSCRAMM® protein technology to Wyeth for the development of staphylococcal vaccines.Keywords: Health, ...
2009 NOV 16 ... to the JAK3 research program by one year. The original research collaboration was with Wyeth, which was acquired by Pfizer in October 2009. By extending the collaboration, Ligand is ...
2009 NOV 16 ... Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, Pfizer and Wyeth Pharmaceuticals. With nine pharmaceutical agreements and more than 20 molecules in ...
2009 NOV 16 ... by one year. The Research and License Agreement entered into in December 2006 with Wyeth provided for an initial three year research term. Under this extension, Ligand will ...
2009 NOV 16 ... Chief Medical Officer J&J Pharmaceuticals and James Kirwin VP Global Clinical Operation Wyeth Pharmaceuticals are uniting with over 50 other figureheads at the renowned NGP US Summit ...
2009 NOV 23 ... million for the same period of 2008, reflecting a decrease in reimbursement revenue from Wyeth (NYSE: WYE) for RELISTOR® research and development under the recently terminated ...
2009 NOV 27 ... information can be obtained by contacting Z.Y. Yang, Wyeth Research, Dept. of Tissue Repair, 200 Cambridge Pk Dr., Cambridge, MA 02140, ...
2009 NOV 16 ... GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, Roche, Sanofi-Aventis, Takeda, and Wyeth. • Clinical/research partners are helping to collect and ...
2009 NOV 23 ... that are expected to launch by 2018 include Roche/Chugai's Omnitarg, Roche's T-DM1 and Wyeth's HKI-272. The report also finds that sales of Roche/Chugai's Avastin for ...
2009 NOV 9 ... Lecturer at Case Western Reserve University. In addition, he recently received the NAMS/Wyeth Pharmaceutical SERMs award from the North American Menopausal Society. About Susan G. ...
2009 NOV 16 ... Bristol-Myers Squibb, sanofi-aventis, GlaxoSmithKline, Genentech, Boehringer Ingelheim, Wyeth Pharmaceuticals, and Daiichi-Sankyo. For more information, please visit the company's ...
2009 NOV 16 ... and $3.6 million for recognition of the $40 million upfront fee received from Wyeth prior to its acquisition by Pfizer. Revenue earned in the nine months ended Sept. 30, ...
2009 NOV 9 ... global accounts for Boehringer-Ingelheim and work as lead creative for the launch of Wyeth's newest antidepressant, Pristiq Agency offices are located at 17 Battery ...
